[Drug therapy of Parkinson's diseases].
D000547:Amantadine / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D000547:Amantadine
Traitement médical de la maladie de Parkinson.